CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer
Status:
Recruiting
Trial end date:
2028-06-01
Target enrollment:
Participant gender:
Summary
Breast cancer is the most common form of cancer among women. For patients candidated for
adjuvant chemotherapy and endocrine therapy the optimal timing for their has not been clearly
defined yet.
Phase:
Phase 3
Details
Lead Sponsor:
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy